INS and Hypoglycemia: Another randomized trial by Ji et al. compared the efficacy and safety of insulin detemir versus NPH in 132 women with pregestational diabetes and 108 with GDM and found that detemir was able to control blood glucose and reached the targets faster and more effectively, with lower incidence of maternal hypoglycemia and comparable adverse birth outcomes [16].